Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Twilio
TWLO
$34.6B
| $1.01M | ﹤0.01% |
+4,900
| New | +$869K |
|
2127
CALL
XPeng
XPEV
$11.7B
| $1.01M | ﹤0.01% |
76,300
-15,200
| -17% | -$241K |
|
2128
Black Diamond Therapeutics
BDTX
$127M
| $1M | ﹤0.01% |
542,172
+31,361
| +6% | +$76.7K |
|
2129
Star Bulk Carriers
SBLK
$3.41B
| $1M | ﹤0.01% |
40,127
+7,257
| +22% | +$188K |
|
2130
CALL
Coupang
CPNG
$29.6B
| $1M | ﹤0.01% |
+57,600
| New | +$1.04M |
|
2131
PUT
Take-Two Interactive
TTWO
$44.8B
| $1,000K | ﹤0.01% |
+4,000
| New | +$883K |
|
2132
Symbotic
SYM
$5.43B
| $998K | ﹤0.01% |
22,208
-62,255
| -74% | -$3.17M |
|
2133
CALL
Lemonade
LMND
$4.13B
| $995K | ﹤0.01% |
+15,300
| New | +$895K |
|
2134
StoneX
SNEX
$8.26B
| $994K | ﹤0.01% |
12,576
+8,742
| +228% | +$656K |
|
2135
PUT
Southern Copper
SCCO
$182B
| $993K | ﹤0.01% |
+5,768
| New | +$1.04M |
|
2136
Autodesk
ADSK
$53.6B
| $989K | ﹤0.01% |
5,087
+1,888
| +59% | +$431K |
|
|
GRMN
2137
Garmin
GRMN
$56.9B
| $984K | ﹤0.01% |
4,141
+1,281
| +45% | +$312K |
|
2138
Itaú Unibanco
ITUB
$82.4B
| $981K | ﹤0.01% |
120,120
-72,456
| -38% | -$600K |
|
2139
CALL
Abbott
ABT
$202B
| $980K | ﹤0.01% |
10,800
-36,000
| -77% | -$3.29M |
|
2140
Celldex Therapeutics
CLDX
$3.17B
| $979K | ﹤0.01% |
26,313
-58,713
| -69% | -$1.9M |
|
2141
PUT
Rio Tinto
RIO
$171B
| $978K | ﹤0.01% |
+10,300
| New | +$1.04M |
|
2142
PUT
KE Holdings
BEKE
$19.6B
| $976K | ﹤0.01% |
67,200
| – | – |
|
2143
MidCap Financial Investment
MFIC
$804M
| $976K | ﹤0.01% |
96,801
+12,024
| +14% | +$132K |
|
2144
Burke & Herbert Financial Services Corp
BHRB
$1.44B
| $976K | ﹤0.01% |
+13,576
| New | +$878K |
|
2145
CALL
Zoom
ZM
$31.5B
| $975K | ﹤0.01% |
11,300
-41,700
| -79% | -$3.94M |
|
2146
Masco
MAS
$14.5B
| $973K | ﹤0.01% |
+11,960
| New | +$834K |
|
2147
OceanFirst Financial
OCFC
$1.84B
| $971K | ﹤0.01% |
49,735
-21,987
| -31% | -$410K |
|
2148
CALL
Amphenol
APH
$194B
| $970K | ﹤0.01% |
5,500
-6,600
| -55% | -$951K |
|
2149
HCI Group
HCI
$2.27B
| $969K | ﹤0.01% |
5,530
-9,912
| -64% | -$1.56M |
|
2150
Casey's General Stores
CASY
$30.9B
| $964K | ﹤0.01% |
1,213
-39,689
| -97% | -$32M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.